SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
62.15
-1.87 (-2.92%)
At close: Mar 9, 2026
105.25%
Market Cap 4.91B
Revenue (ttm) 819.09M
Net Income (ttm) 121.55M
Shares Out 79.00M
EPS (ttm) 1.38
PE Ratio 45.08
Forward PE 45.04
Dividend 0.27 (0.42%)
Ex-Dividend Date Nov 28, 2025
Volume 1,377,385
Average Volume 1,887,163
Open 62.03
Previous Close 64.02
Day's Range 60.60 - 63.14
52-Week Range 24.18 - 85.00
Beta 1.18
RSI 45.23
Earnings Date Apr 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,271
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements

News

There is no news available yet.